Two MedStar Health hospitals are now offering an FDA-approved treatment for patients who have had persistent atrial fibrillation for more than a year. The Hybrid AF™ Convergent Therapy is available both at MedStar Washington Hospital Center and MedStar Union Memorial Hospital in Baltimore.
Atlantic Health System’s Morristown Medical Center, one of the nation’s leading heart hospitals, will host a virtual conference featuring some of the world’s most distinguished cardiovascular faculty, who will discuss the latest developments in heart disease. This program is cosponsored by the NJ Chapter of the American College of Cardiology.
To help prevent a stroke — a common and serious risk associated with AFib — patients are treated with blood thinners. But for some, the medication itself can be risky.
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
The Valley Hospital in Ridgewood, NJ, has become the first center in the world to utilize leading-edge imaging software designed to enhance the safety and efficacy of a Watchman implant procedure.
Rockville, Md. (November 25, 2020)—Atrial fibrillation is the most frequent arrhythmia in both equine and human athletes. In this study, researchers investigated whether the arrhythmogenic substrate—the preexisting condition that causes arrhythmia—present between the episodes of paroxysmal atrial fibrillation (PAF) can…
New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.
September is National Atrial Fibrillation Month, and Stephen L. Winters, MD, director of the Cardiac Rhythm Management Program, Gagnon Cardiovascular Institute, Atlantic Health System’s Morristown Medical Center, wants the public to know some surprising facts about this increasingly common heart condition.
New generation implant has improved safety and performance features for those with atrial fibrillation
The Cardiovascular Research Foundation (CRF) will hold a free online seminar, “Get Heart Smart,” on August 24 hosted by Drs. Nisha Jhalani and Ajay Kirtane, renowned academic cardiologists from NewYork-Presbyterian/Columbia University Irving Medical Center. The seminar, part of a series of “Mini Med Schools” conducted by the CRF Women’s Heart Health Initiative, will focus on common heart disease symptoms, when to talk to your doctor, and when to seek emergency care.
Atrial fibrillation ranks among the most common heart conditions, and episodes are difficult to predict. Researchers have proposed a way to define cardiac state and have studied the dynamics before the cardiac rhythm changes from normal sinus to AF rhythm and vice versa. The work, appearing in Chaos and based on critical transition theory, looks to provide an early warning for those with paroxysmal atrial fibrillation with potential implications for future wearable devices.
Mapping the electrical conductivity of the heart would be a valuable tool in diagnosis and disease management, but doing so would require invasive procedures, which aren’t capable of directly mapping dielectric properties. Significant advances have recently been made that leverage atomic magnetometers to provide a direct picture of electric conductivity of biological tissues, and in Applied Physics Letters, new work in quantum sensors points to ways such technology could be used to examine the heart.
Only 1 in 13 everyday patients could have participated in a pivotal international clinical trial looking at the use of catheter ablation to treat atrial fibrillation (AFib) among people with heart failure. However, new Mayo Clinic research provides evidence supporting the benefit of ablation, and shows what the outcomes might be for everyday patients. The Mayo study will be published in Heart Rhythm Journal.
Cardiologists at The Ohio State University Wexner Medical Center are the first in the U.S. to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
A new study from researchers at the University of Illinois at Chicago is the first to show that some antiarrhythmic medications used to treat AFib are less effective in patients who are obese. The results of this study, which followed more than 300 patients in the UIC AFib Registry, are published in JAMA Cardiology.
A quality improvement project at Beaumont Hospital in Michigan resulted in a decreased incidence of postoperative atrial fibrillation and shorter mean lengths of stay. The results indicate that an amiodarone POAF prophylaxis protocol could significantly reduce costs, improve patient outcomes and increase the overall quality of care.
A small genetic study, published September 30, 2019 in Nature Genetics, identified a protein linked to many genetic variants that affect heart function. Researchers are expanding the model to other organ systems and at larger scales to create a broader understanding of genes and proteins involved.